The company released its third quarter results Nov. 6.
Three notes on the company’s third quarter performance:
1. Alphatec saw a 24% increase in surgical volume and a 6% increase in average revenue per procedure.
2. The company brought in $150 million in capital to increase investment in implants and instrument sets.
3. The company reported an ending cash balance of $123 million.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
